All Stories

  1. Ablation of neuropilin-1 improves the therapeutic response in conventional drug-resistant glioblastoma multiforme

    Article • Oncogene, October 2020, Springer Science + Business Media

    Dr VIJAY SAGAR MADAMSETTY

  2. In vivo gene delivery mediated by non-viral vectors for cancer therapy

    Article • Journal of Controlled Release, September 2020, Elsevier

    Dr VIJAY SAGAR MADAMSETTY

  3. Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemia

    Article • Leukemia & Lymphoma, June 2020, Taylor & Francis

    Dr VIJAY SAGAR MADAMSETTY

  4. Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics

    Article • Advanced Functional Materials, June 2020, Wiley

    Dr VIJAY SAGAR MADAMSETTY

  5. Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer

    Article • Cancers, May 2020, MDPI AG

    Dr VIJAY SAGAR MADAMSETTY

  6. Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer

    Article • International Journal of Molecular Sciences, January 2020, MDPI AG

    Dr VIJAY SAGAR MADAMSETTY

  7. Functionalization of Nanomaterials and Their Application in Melanoma Cancer Theranostics

    Article • ACS Biomaterials Science & Engineering, December 2019, American Chemical Society (ACS)

    Dr VIJAY SAGAR MADAMSETTY

  8. Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer

    Article • npj Precision Oncology, December 2019, Springer Science + Business Media

    Dr VIJAY SAGAR MADAMSETTY

  9. Recent Trends of the Bio-Inspired Nanoparticles in Cancer Theranostics

    Article • Frontiers in Pharmacology, October 2019, Frontiers

    Dr VIJAY SAGAR MADAMSETTY

  10. Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic Ductal Adenocarcinoma

    Article • Bioconjugate Chemistry, October 2019, American Chemical Society (ACS)

    Dr VIJAY SAGAR MADAMSETTY

  11. Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC

    Article • International Journal of Nanomedicine, July 2019, Dove Medical Press

    Dr VIJAY SAGAR MADAMSETTY

  12. Tumor selective uptake of drug-nanodiamond complexes improves therapeutic outcome in pancreatic cancer

    Article • Nanomedicine Nanotechnology Biology and Medicine, March 2019, Elsevier

    Dr VIJAY SAGAR MADAMSETTY

  13. Neuropilin-1 maintains dimethylarginine dimethylaminohydrolase 1 expression in endothelial cells, and contributes to protection from angiotensin II–induced hypertension

    Article • The FASEB Journal, January 2019, Federation of American Societies For Experimental Biology (FASEB)

    Dr Sanjay Misra, Dr VIJAY SAGAR MADAMSETTY

  14. Development of multi-drug loaded PEGylated nanodiamonds to inhibit tumor growth and metastasis in genetically engineered mouse models of pancreatic cancer

    Article • Nanoscale, January 2019, Royal Society of Chemistry

    Dr VIJAY SAGAR MADAMSETTY

  15. Abstract 2926: The glycogen synthase kinase-3 inhibitor, 9-ING-41, synergizes with chemotherapy to inhibit pancreatic tumor growth in vivo

    Article • Cancer Research, July 2018, American Association for Cancer Research (AACR)

    Dr VIJAY SAGAR MADAMSETTY

  16. Synthesis, Spectral Characterization, DNA/ Protein Binding, DNA Cleavage, Cytotoxicity, Antioxidative and Molecular Docking Studies of Cu(II)Complexes Containing Schiff Base-bpy/Phen Ligands

    Article • Journal of Fluorescence, January 2017, Springer Science + Business Media

    Dr VIJAY SAGAR MADAMSETTY

  17. Liposomally encapsulated CDC20 siRNA inhibits both solid melanoma tumor growth and spontaneous growth of intravenously injected melanoma cells on mouse lung

    Article • Drug Delivery and Translational Research, March 2013, Springer Science + Business Media

    Dr VIJAY SAGAR MADAMSETTY